Z A Martinez
Overview
Explore the profile of Z A Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farid M, Martinez Z, Geyer M, Swerdlow N
Neuropsychopharmacology
. 2000 Nov;
23(6):623-32.
PMID: 11063918
Sensorimotor gating of the startle reflex can be assessed via measures of prepulse inhibition (PPI), which is the reduction in startle magnitude when the startling stimulus is preceded immediately by...
2.
Martinez Z, Oostwegel J, Geyer M, Ellison G, Swerdlow N
Neuropsychopharmacology
. 2000 Oct;
23(5):517-27.
PMID: 11027917
Both dopamine (DA) agonists and NMDA antagonists produce prepulse inhibition (PPI) deficits in rats that model PPI deficits in schizophrenia patients. While DA agonist effects on PPI are reversed by...
3.
Swerdlow N, Martinez Z, Hanlon F, Platten A, Farid M, Auerbach P, et al.
J Neurosci
. 2000 May;
20(11):4325-36.
PMID: 10818168
Sensorimotor gating, measured by prepulse inhibition (PPI) of the startle reflex, is reduced in schizophrenia patients and in rats treated with dopamine agonists. Strain differences in the sensitivity to the...
4.
Martinez Z, Halim N, Oostwegel J, Geyer M, Swerdlow N
Pharmacol Biochem Behav
. 2000 Feb;
65(3):449-57.
PMID: 10683485
NMDA antagonists and dopamine (DA) agonists produce neuropathological and/or behavioral changes in rats that may model specific abnormalities in schizophrenia patients. In adult rats, NMDA antagonists and DA agonists disrupt...
5.
Martinez Z, Ellison G, Geyer M, Swerdlow N
Neuropsychopharmacology
. 1999 Jun;
21(1):28-39.
PMID: 10379517
Phencyclidine (PCP), a non-competitive NMDA antagonist with actions at multiple other central nervous system receptors, can cause both acute and lasting psychoses in humans, and has also been used in...
6.
Martinez Z, Ellison G, Geyer M, Swerdlow N
Psychopharmacology (Berl)
. 1999 Apr;
142(3):253-60.
PMID: 10208317
Deficient sensorimotor gating, as measured by a relative loss of prepulse inhibition (PPI) of the startle reflex, has been reported in schizophrenia patients and in rats treated acutely with dopamine...
7.
Martinez Z, Colgan M, Baxter Jr L, Quintana J, Siegel S, Chatziioannou A, et al.
Am J Primatol
. 1997 Jan;
42(3):215-24.
PMID: 9209586
We describe a method of orally administering 18F-fluoro-2-deoxyglucose (FDG) for positron emission tomography (PET) scans to determine local cerebral metabolic rates for glucose (LCMRGlc), normalized to that of whole brain,...